Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis

Journal of Infectious Diseases

Volumn 187, Issue SUPPL. 2, 2003, Pages

  Calandra, Thierry ^a   Froidevaux, Céline ^a   Martin, Christian ^a   Roger, Thierry ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; TOLL LIKE RECEPTOR 4;

ANTIBODY DEPENDENT ENHANCEMENT; ANTIGEN RECOGNITION; CONFERENCE PAPER; EFFECTOR CELL; EXPERIMENTAL INFECTION; GENE STRUCTURE; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; HUMAN; MACROPHAGE MIGRATION INHIBITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; TISSUE DISTRIBUTION;

ANIMALS; BACTERIAL INFECTIONS; BACTERIAL TOXINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; SEPSIS;

EID: 0038010523     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374752     Document Type: Conference Paper

References (48)

1. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a non-clonal system of recognition. Cell 1997; 91:295-8.
2. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999; 284:1313-8.
3. Kimbrell DA, Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet 2001; 2:256-67.
4. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966; 153:80-2.
5. David J. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966; 56:72-7.
6. Calandra T, Bucala R. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 1997; 17:77-88.
7. Weiser WY, Temple PA, Witek-Gianotti JS, Remold HG, Clark SC, David JR. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1989; 86:7522-6.
8. Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365:756-9.
9. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994; 33:14144-55.
10. Paralkar V, Wistow G. Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 1994; 19:48-51.
11. Wistow GJ, Shaughnessy MP, Lee DC, Hodin J, Zelenka PS. A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci USA 1993; 90:1272-5.
12. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin M, Bucala R. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 1995; 154:3863-70.
13. Kozak CA, Adamson MC, Buckler CE, Segovia L, Paralkar V, Wistow G. Genomic cloning of mouse MIF (macrophage inhibitory factor) and genetic mapping of the human and mouse expressed gene and nine mouse pseudogenes. Genomics 1995; 27:405-11.
14. Bozza M, Kolakowski LF Jr, Jenkins NA, et al. Structural characterization and chromosomal location of the mouse macrophage migration inhibitory factor gene and pseudogenes. Genomics 1995; 27:412-9.
15. Esumi N, Budarf M, Ciccarelli L, Sellinger B, Kozak CA, Wistow G. Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIE Mamm Genome 1998; 9:753-7.
16. Ishizaka K, Ishii Y, Nakano T, Sugie K. Biochemical basis of antigen-specific suppressor T cell factors: controversies and possible answers. Adv Immunol 2000; 74:1-60.
17. Sugimoto H, Taniguchi M, Nakagawa A, Tanaka I, Suzuki M, Nishihira J. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. Biochemistry 1999; 38:3268-79.
18. Sun HW, Bernhagen J, Bucala R, Lolis E. Crystal structure at 2.6Å resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1996; 93:5191-6.
19. Suzuki M, Sugimoto H, Nakagawa A, Tanaka I, Nishihira J, Sakai M. Crystal structure of the macrophage migration inhibitory factor from rat liver. Nat Struct Biol 1996; 3:259-66.
20. Subramanya HS, Roper DI, Dauter Z, et al. Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry 1996; 35:792-802.
21. Swope MD, Lolis E. Macrophage migration inhibitory factor: cytokine, hormone, or enzyme? Rev Physiol Biochem Pharmacol 1999; 139:1-32.
22. Rosengren E, Bucala R, Åman P, et al. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) calalyzes a tautomerization reaction. Mol Med 1996; 2:143-9.
23. Rosengren E, Aman P, Thelin S, et al. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett 1997; 417:85-8.
24. Kleemann R, Kapurniotu A, Frank RW, et al. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-prorein oxidoreductase. J Mol Biol 1998; 280:85-102.
25. Bendrat K, Al-Abed Y, Callaway DIE, et al. Biochemical and mutational investigations of the enzymatic activity, of macrophage migration inhibitory factor. Biochemistry 1997; 36:15356-62.
26. Hermanowski-Vosatka A, Mundt SS, Ayala JM, et al. Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 1999; 38:12841-9.
27. Lubetsky JB, Dios A, Han J, et al. The tautomerase activity of MIF is a potential target for discovery of novel anti-inflammatory agents. J Biol Chem 2002; 277:24976-82.
28. Kleemann R, Rorsman H, Rosengren E, Mischke R, Mai NT, Bernhagen J. Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor: full immunologic activity of N-terminally truncated mutants. Eur J Biochem 2000; 267:7183-93.
29. Bacher M, Meinhardt A, Lan HY, et al. MIF expression in experimentally-induced endotoxemia. Am J Pathol 1997; 150:235-46.
30. Waeber G, Calandra T, Roduit R, et al. Insulin secretion is regulated by the glucose-dependent production of islet B-cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1997; 94:4782-7.
31. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179:1895-902.
32. Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377:68-71.
33. Calandra T, Spiegel LA, Metz CN, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria. Proc Natl Acad Sci USA 1998; 95:11383-8.
34. Martiney JA, Sherry B, Metz CN, et al. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun 2000; 68:2259-67.
35. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996; 93:7849-54.
36. Leech M, Metz C, Hall P, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42:1601-8.
37. Mitchell RA, Metz CN, Peng T, Bucala R. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phopholipase A2 activation by macrophage migration inhibitory factor (MIF). J Biol Chem 1999; 274:18100-6.
38. Mitchell RA, Liao H, Chesney J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002; 99:345-50.
39. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999; 190:1375-82.
40. Roger T, David J, Glauser MP, Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001; 414:920-4.
41. Bozza M, Satoskar AR, Lin G, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999; 189:341-6.
42. Calandra T, Echtenacher B, Roy DL, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6:164-70.
43. Echtenacher B, Falk W, Männel DN, Krammer PH. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145:3762-6.
44. Heumann D, Le Roy D, Zanetti G, et al. Contribution of TNF/TNF receptor and of Fas ligand to toxicity, in murine models of endotoxemia and bacterial peritonitis. J Inflamm 1995-96; 47:173-9.
45. Pfeffer K, Matsuyama T, Kündig TM, et al. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993; 73:457-67.
46. Rothe J, Lesslauer W, Lötscher H, et al. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993; 364: 798-802.
47. Le Roy D, Di Padova F, Adachi Y, Glauser MP, Calandra T, Heumann D. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J Immunol 2001; 167:2759-65.
48. Beishuizen A, Thijs LG, Haanen C, Vermes I. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 2001; 86:2811-6.